Cargando…
Sustained Transmission of Neisseria gonorrhoeae Strains with High-Level Azithromycin Resistance (MIC ≥ 256 μg/mL) in Argentina, 2018 to 2022
Azithromycin combined with ceftriaxone is the recommended dual therapy for uncomplicated gonorrhea in many countries. Nevertheless, the increasing prevalence of azithromycin resistance compromises the effectiveness of this treatment strategy. From 2018 to 2022, we collected 13 gonococcal isolates wi...
Autores principales: | Gianecini, Ricardo Ariel, Poklepovich, Tomas, Golparian, Daniel, Cuenca, Noelia, Scocozza, Laura, Bergese, Silvina, Canigia, Liliana Fernández, Vilches, Viviana, Lazzarino Elgart, María Julia, Unemo, Magnus, Campos, Josefina, Galarza, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433793/ https://www.ncbi.nlm.nih.gov/pubmed/37338369 http://dx.doi.org/10.1128/spectrum.00970-23 |
Ejemplares similares
-
Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005–2019
por: Gianecini, Ricardo Ariel, et al.
Publicado: (2021) -
Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina
por: Gianecini, Ricardo, et al.
Publicado: (2016) -
Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022
por: Pleininger, Sonja, et al.
Publicado: (2022) -
Now Is the Time to Implement Whole Genome Sequencing in the Global Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae?
por: Golparian, Daniel, et al.
Publicado: (2019) -
WGS to predict antibiotic MICs for Neisseria gonorrhoeae
por: Eyre, David W., et al.
Publicado: (2017)